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Abstract 
To examine the cell-protective role of podocyte autophagy against glomerular endothelial 
dysfunction in diabetes, we analyzed the renal phenotype of tamoxifen (TM)-inducible 
podocyte-specific Atg5-deficient (iPodo-Atg5-/-) mice with experimental endothelial 
dysfunction. In both control and iPodo-Atg5-/- mice, high fat diet (HFD) feeding induced 
glomerular endothelial damage characterized by decreased urinary nitric oxide (NO) 
excretion, collapsed endothelial fenestrae, and reduced endothelial glycocalyx. HFD-fed 
control mice showed slight albuminuria and nearly normal podocyte morphology. In 
contrast, HFD-fed iPodo-Atg5-/- mice developed massive albuminuria accompanied by 
severe podocyte injury that was observed predominantly in podocytes adjacent to 
damaged endothelial cells by scanning electron microscopy. Although podocyte-specific 
autophagy deficiency did not affect endothelial NO synthase deficiency-associated 
albuminuria, it markedly exacerbated albuminuria and severe podocyte morphological 
damage when the damage was induced by intravenous neuraminidase injection to remove 
glycocalyx from the endothelial surface. Furthermore, endoplasmic reticulum stress was 
accelerated in podocytes of iPodo-Atg5-/- mice stimulated with neuraminidase, and 
treatment with molecular chaperone tauroursodeoxycholic acid improved neuraminidase-
induced severe albuminuria and podocyte injury. In conclusion, podocyte autophagy 
plays a renoprotective role against diabetes-related structural endothelial damage, 
providing an additional insight into the pathogenesis of massive proteinuria in diabetic 
nephropathy. 
 





Massive proteinuria is a strong risk for renal dysfunction in diabetic kidney disease 
(DKD) [1,2]. Thus, revealing the mechanism underlying this condition is urgently 
required. The glomerular filtration barrier consists of an endothelium, glomerular 
basement membrane, and podocytes. Among these components, podocyte damage is 
strongly associated with massive proteinuria in DKD [3,4]. However, considering that 
DKD is initially characterized by a microvascular complication, in which endothelial 
damage is considered as the first event [5,6], there must be a mechanism of progression 
from endothelial to podocyte damage. 
 Glomerular endothelial cells have a unique structural feature characterized by 
fenestration to filter waste products and glycocalyx with a negative charge to prevent 
albumin leakage into urine [7-9]. Furthermore, endothelial cells functionally secrete nitric 
oxide (NO) in nitric oxide synthase 3 (NOS3)-dependent manner to maintain a normal 
glomerular environment [10]. Metabolic alterations in diabetes impair endothelial cells, 
leading to microalbuminuria. Furthermore, the endothelial damage has been reported to 
be involved in the development of podocyte damage [11,12]. However, the pathological 
process from endothelial damage to podocyte damage in diabetes has not been fully 
understood. 
 Autophagy is an intracellular degradation system that overcomes various stress 
conditions in many cell types [13]. Autophagic activity in podocytes is considerably 
higher than in other mammalian cell type [14], suggesting that this system is essential for 
podocyte functions. Some reports demonstrated that podocyte autophagy plays cell-
protective roles in diabetes [15], however its role in podocyte protection against 
glomerular endothelial cell damage in diabetes has not been elucidated.  
In this study, we hypothesized that autophagy is required to protect podocytes 
from cytotoxic stress related to endothelial damage in diabetes, and that impaired 
podocyte autophagy is involved in the progression from endothelial to podocyte damage 
in DKD. To test these hypotheses, we analyzed the renal phenotypes of a newly 
established inducible podocyte-specific autophagy-deficient mouse model under 




Characterization of functional and structural endothelial damage in high-fat diet 
(HFD)-induced diabetic mice 
HFD treatment increased body weight gain and fasting blood glucose levels during 32 
weeks of dietary intervention compared with mice fed the standard diet (STD) (Fig. 1A 
and B). In HFD-fed mice, urinary NO excretion was significantly decreased from 4 weeks 
after the dietary intervention compared with STD-fed mice (Fig. 1C). Changes in 
endothelial cell morphology were characterized by the disappearance of endothelial 
fenestrae and increasing microblebs in scanning electron microscopy (EM) analysis and 
decreased glycocalyx determined by isolectin and wheat germ agglutinin (WGA) staining 
started from 8 weeks after HFD feeding (Fig. 1D). These results suggested that the HFD 
intervention caused both functional and structural endothelial damage in glomeruli of 
mice. 
 
Generation of tamoxifen (TM)-inducible podocyte-specific Atg5-deficient (iPodo-
Atg5-/-) mice 
Eight-week-old male Atg5f/f mice and Atg5f/f mice carrying podocyte-specific CreERT2 
were fed either the STD or HFD (Supplemental Fig. 1A). Then, TM was injected into the 
mice at 8 weeks after the dietary intervention to delete the Atg5 gene in podocytes. 
 At 8 weeks after the TM injection, the HFD-induced body weight gain and 
increase in fasting blood glucose levels were not different between both genotypes 
(Supplemental Fig. 1B and C). SQSTM1 protein accumulation is an indicator of cellular 
autophagy insufficiency [16]. SQSTM1 was accumulated in the podocytes of STD-fed 
iPodo-Atg5-/- mice, which was increased by HFD feeding (Fig. 2A). These data indicated 
that the HFD-induced obese diabetic condition increased the need for autophagy in 
podocytes. 
  
Severe podocyte injury in HFD-fed iPodo-Atg5-/- mice 
HFD intervention increased urinary albumin excretion in control mice, which was 
exacerbated in HFD-fed iPodo-Atg5-/- mice at 4 and 8 weeks after the TM injection (Fig. 
2B and C). Although glomerular sclerotic lesions induced by HFD feeding were similar 
between two genotypes, podocyte foot process effacement in scanning EM and decreased 
podocin expression were more severe in HFD-fed iPodo-Atg5-/- mice (Fig. 2A). In 
addition, podocin staining became pathogenically granular pattern in HFD-fed iPodo-
Atg5-/-, and the podocyte number determined by counting WT-1-positive cells was 
significantly decreased in HFD-fed iPodo-Atg5-/- mice (Fig. 2A and D). 
  
Pathological interaction between endothelial damage and deficient podocyte 
autophagy in podocyte damage of HFD-fed iPodo-Atg5-/- mice 
Next, we evaluated the spatial interaction between damaged endothelial cells and 
damaged podocytes by scanning EM (Fig. 3A). HFD-fed Atg5f/f mice showed a normal 
podocyte architecture despite being adjacent to damaged endothelial cells (Fig. 3A). In 
HFD-fed iPodo-Atg5-/- mice, podocyte injury was observed particularly in the podocytes 
adjacent to damaged endothelial cells. However, if an endothelial cell was undamaged, 
the adjacent podocytes retained their normal morphology (Fig. 3A). To confirm this 
pathological interaction, we conducted isolectin and desmin double staining 
(Supplemental Fig. 2A-D). Desmin expression is a marker of podocyte damage. In HFD-
fed Atg5f/f mice, desmin staining was less observed regardless of positive or negative 
staining by isolectin (Supplemental Fig. 2A and B), whereas in HFD-fed iPodo-Atg5-/- 
mice, desmin staining was markedly observed particularly nearby podocytes, where 
isolectin staining was absent (Supplemental Fig. 2C and D). These results suggested that 
endothelial cell damage was a trigger of podocyte damage in HFD-fed iPodo-Atg5-/- mice. 
 
No involvement of NO deficiency in severe injury of autophagy-deficient podocytes 
Because HFD-fed mice showed functional and structural endothelial damage, we next 
elucidated which played the main pathological role in severe podocyte injury of diabetic 
mice with deficient podocyte autophagy. To this end, we first generated iPodo-Atg5-/- 
mice lacking NOS3 systemically (Supplemental Fig. 3A). NOS3-/- mice showed mild 
albuminuria at 4 and 8 weeks after the TM injection, but this albuminuria was not 
enhanced by the autophagy deficiency in podocytes (Supplemental Fig. 3B and C). 
Furthermore, morphological changes of podocyte foot processes, podocin expression 
levels (Supplemental Fig. 3D), suggesting that functional endothelial damage was not a 
trigger of podocyte injury in HFD-fed iPodo-Atg5-/- mice. 
 
Pathological role of glycocalyx disappearance in severe injury of autophagy-
deficient podocytes 
We next examined a possibility that structural endothelial damage might be involved in 
severe podocyte injury of HFD-fed iPodo-Atg5-/- mice. To examine this possibility, we 
used neuraminidase that transiently removes endothelial glycocalyx. In fact, an 
intravenous injection of neuraminidase decreased the density of WGA staining at day 1 
after the injection, which was recovered at day 3 after the injection, although nephrin 
expression was not altered (Supplemental Fig. 4A). Neuraminidase was then injected into 
in STD-fed Atg5f/f mice and STD-fed iPodo-Atg5-/- mice (Supplemental Fig. 4B). The 
neuraminidase treatment led to mild transient albuminuria in STD-fed Atg5f/f mice (Fig. 
3B). Podocyte autophagy deficiency significantly magnified the albuminuria at days 1 
and 2 after the injection (Fig.3B), which was accompanied by alterations of the foot 
process structure and podocin expression pattern (Fig. 3C and supplemental Fig.4C). 
These results suggested that podocyte autophagy has a podocyte protective role against 
structural endothelial cell damage. 
 
Pathological role of albumin in cell damage in autophagy-deficient podocytes. 
Because removal of glycocalyx should increase albumin leaking into Bowman’s space, 
leading to high exposure of albumin to podocytes, we hypothesized that increased 
albumin exposure caused cell damage in autophagy-deficient podocytes. To explore this 
hypothesis, we used cultured autophagy-deficient podocytes. The protein coded by the 
Atg7 gene is essential for autophagosome formation [15,17]. We stimulated the cultured 
Atg7-deficient podocytes and control Atg7f/f podocytes with albumin. Albumin treatment 
increased apoptosis determined by cleavage of caspase 3, which was enhanced by 
autophagy deficiency (Fig. 4A and B).  
 
Involvement of enhanced endoplasmic reticulum (ER) stress in severe podocyte 
injury of autophagy-deficient podocytes exposed to albumin 
To determine which intracellular pathway or whether organelle damage was associated 
with the enhanced apoptosis in autophagy-deficient podocytes stimulated by albumin, 
proteomic analysis followed by pathway analysis related to apoptosis events was applied. 
The analysis suggested that enhanced ER stress was strongly involved in the autophagy-
deficiency-related acceleration of apoptosis in podocytes (Fig. 4C). In fact, in the 
podocytes of STD-fed iPodo-Atg5-/- mice treated with neuraminidase, C/EBP 
homologous protein (CHOP), an inducer of ER stress-related apoptosis [18,19], was 
increased significantly (Fig. 4D). Finally, the mice were treated with 
tauroursodeoxycholic acid (TUDCA), a molecular chaperone, to enhance ER capacity 
and subsequently reduce ER stress [20]. TUDCA treatment significantly decreased 
urinary albumin excretion (Fig. 4E). Furthermore, the altered foot process structure and 
podocin expression pattern were ameliorated by TUDCA treatment in STD-fed iPodo-




The present study provides the evidence that podocyte autophagy is of particular 
importance to protect cells against endothelial damage-related cytotoxicity in diabetes. 
 One of main points in this study is that we used a drug-inducible podocyte-
specific autophagy-deficient mouse model. Previous studies, including ours, have used a 
congenital genetically modified mouse model [14,15]. It has been a concern that 
enhancement of a decomposition system other than autophagy may occur in a 
compensating manner in podocytes of this mouse model. In fact, in our previous study, 
congenital podocyte-specific autophagy-deficient mice showed severe podocyte injury 
after 32 weeks of HFD intervention [15], whereas the inducible autophagy-deficient mice 
developed severe damage after only 8 weeks of HFD intervention. These results support 
such a concern and provide evidence that autophagy per se is an important cell-protective 
mechanism during disease states including diabetes. 
 As shown in this study, two types of endothelial abnormality are characterized 
during the development of HFD-induced obese diabetes. One is a structural alteration 
with decreased glycocalyx, and the other is functional damage by NO deficiency. The NO 
deficiency is strongly associated with progression of podocyte damage in diabetes [11], 
which is partly associated with mitochondrial damage. Damaged mitochondria can be 
removed by autophagy machinery [21]. Therefore, we initially hypothesized that 
podocyte-specific autophagy deficiency may exacerbate podocyte injury due to the NO 
deficiency by enhancing mitochondrial damage. However, this was not observed. In 
contrast, the autophagy deficiency worsened podocyte injury mediated by neuraminidase-
mediated removal of glycocalyx, the structural barrier in glomeruli, suggesting that 
podocyte autophagy removes a cytotoxic molecule that passes through the damaged 
endothelium. Based on our results, serum albumin may be a candidate molecule that 
causes podocyte injury during endothelial damage, and autophagy protects podocytes 
from albumin-induced cytotoxicity.  
 A high level of basal autophagy in podocytes has been reported [14], although 
its exact role remains unclear. Based on our results, podocytes may maintain basal 
autophagy at a high level to rapidly respond to cellular toxicity caused by abrupt 
endothelial damage. If this is the case, in the situation of diabetes leading to endothelial 
damages, it is not surprising that autophagy insufficiency leads to severe podocyte 
damage. In clinical settings, even if patients show hyperglycemia to the same extent, the 
incidence and progression of proteinuria vary from person to person. The difference in 
the vulnerability of cytoprotective mechanisms including podocyte autophagy in an 
individual may be responsible for the variety of renal manifestations in diseases 
associated with endothelial damage. To protect terminally differentiated podocytes that 
do not have a replicative capacity, mammals may have developed dual protective systems, 
an endothelial glycocalyx-related structural barrier and intracellular adaptive mechanism 
in podocytes against certain serum factors that pass through the damaged endothelium, 
and diabetes may disturb both. 
 Autophagy targets various organelles under stress conditions, such as 
mitochondria, ER, peroxisomes, and lysosomes [22,23]. Among these, ER appears to be 
a target to be protected by autophagy in podocytes during structural endothelial damage. 
ER stress has been reported to be involved in the pathogenesis of podocyte damage in 
DKD [24,25], but the mechanism underlying enhanced diabetes-related ER stress has not 
been fully elucidated. Autophagy insufficiency may be involved in the diabetes-related 
enhancement of ER stress, and amelioration of the altered autophagy-ER axis in diabetes 
may be an effective to prevent the progression of DKD with massive proteinuria. 
 Some issues remain in this study. First, which serum factors pass through the 
damaged endothelium and cause podocyte damage have not been clearly identified. 
Based on our study, albumin is a candidate molecule, but there may be other factors 
involved in the pathology. In particular, increased levels of fatty acid-bound albumin and 
advanced glycated end-products in diabetes may be more toxic than pure albumin [5,26]. 
Identifying the serum factor(s) may facilitate development of a novel therapeutic strategy 
for DKD. Second, a reason why deficient autophagy did not exacerbate albuminuria in 
NOS3-/- mice remains unclear. Our cell culture study clearly showed that albumin 
stimulation worsened apoptosis in the autophagy-deficient podocytes, but podocyte 
autophagy deficiency in mice did not show severe albuminuria in NOS3-/- mice although 
they showed mild albuminuria. Considering that NOS3-/--iPodo-Atg5-/- kept almost 
normal endothelial structure, there might be some difference in significance or cause 
between NOS3 deficiency-dependent albuminuria and structural damage-dependent 
albuminuria. Further examination is required to conclude this concern. 
 In conclusion, autophagy protects podocytes from diabetes-related structural 
endothelial damage. Insufficient autophagy leads to severe podocyte injury and 
subsequent massive albuminuria by activation of ER stress during the development of 
endothelial damage in DKD. The present findings suggest a novel role of podocyte 
autophagy in the pathogenesis of DKD and shed new light on the development of 
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Periodic acid-Schiff (PAS) staining, immunofluorescence, and immunohistochemistry 
analyses were performed as described previously [27]. Antibodies against SQSTM1 
(MBL, Tokyo, Japan), WT1 (Santa Cruz Biotechnology, Santa Cruz, CA), podocin 
(Sigma-Aldrich), nephrin (PROGEN, Heidelberg, Germany), desmin, and CHOP (Cell 
Signaling, Danvers, MA) were used. Corresponding fluorescently labeled secondary 
antibodies (goat anti-mouse IgG-Alexa, goat anti-rabbit IgG-Alexa, and goat anti-rat IgG-
Alexa Sigma-Aldrich) were used. Two kinds of lectins, isolectin (Isolectin GS-IB4 from 
griffonia simplicifolia) and WGA from Thermo Fisher (Waltham, MA) were used to 
evaluate glycocalyx. EM analyses were performed with an S-570 and H-7500 (Hitachi, 
Tokyo, Japan). To determine the podocyte number, WT1-positive cells were counted in 
more than 10 glomeruli in each mouse sample. To determine ER stress in podocytes, 
CHOP-positive cells in glomeruli were counted in more than 10 glomeruli in each mouse 
sample. 
 
Blood and urinary analyses  
Blood glucose levels were measured using a Glutest sensor (SanwaKagaku, Nagoya, 
Japan). Urinary albumin excretions were measured by a turbidimetric immunoassay and 
urinary creatine levels were measured by an enzytec generic (ORIENNTAL YEASR Co., 
LTD, Tokyo, Japan). Urinary albumin excretion levels are expressed as log10 ratio urinary 
albumin/creatinine. Urinary NO excretion levels were measured by a fluorometric nitric 
oxide assay kit (abcam, Cambridge, UK). 
 
Western blot analysis 
An Atg7-deficient podocyte cell line was established with the pMESVTS plasmid 
containing a SV40 large T antigen [28]. Glomeruli of podocyte-specific Atg7-deficient 
[17,29] and wildtype mice were isolated using Dynabeads M-450 Tosylactivated 
(Invitrogen, Carlsbad, CA) [30]. Podocytes were infected with a viral supernatant from 
PLAT-E cells transfected with the pMESVTS plasmid [31] and maintained in RPMI-1640 
with 10% FBS at 33°C. The cells were cultured at 39°C to induce differentiation over 7 
days. Proten samples were collected from differentiated Atg-7-deficient and wildtype 
podocytes stimulated with 5 g/dl bovine serum albumin for 30 hours. Western blot 
analysis was performed as described previously [32]. The membranes were incubated 
with antibodies against cleaved caspase 3 (Asp175) (Cell Signaling Technology, Danvers, 
MA), Atg7 (Cell Signaling Technology, Danvers, MA), or β-actin (Sigma-Aldrich).  
 
Proteomic analyses 
The proteomic analysis was conducted by Medical Proteoscope (Kanagawa, Japan). 
Whole data are included as Supplemental Data. Proteomic analysis was performed as 
previously reported [33]. Method for Bioinformatic analysis is described in Supplemental 
Method. 
 
Statistical Analyses  
Results are expressed as the mean ± SEM. Analysis of variance and Tukey’s post-hoc test 
were used to determine significant differences for multiple comparisons. The Student’s t-
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Figure 1. High-fat diet (HFD)-induced functional and structural glomerular 
endothelial cell damage. (A and B) Changes in body weight (A) and fasting blood 
glucose levels (B) in mice fed either standard diet (STD) or HFD during the 32-week 
experimental period. (C) Urinary nitric oxide (NO) levels in the two groups of mice. (D) 
Time-dependent structural changes in glomerular endothelial cells of HFD-fed mice. 
Scanning electron microscopy (EM) and immunofluorescence (IF) for isolectin and 
Wheat Germ Agglutinin (WGA). Original magnification, ×20,000 for scanning EM, 
×1,000 for IF. All results are presented as mean ± SEM. *P < 0.05, **P < 0.01. NS: not 
significant. 
 
Figure 2. Severe podocyte injury in high-fat diet (HFD)-fed iPodo-Atg5-/- mice. (A) 
Representative pictures of immunohistochemistry (IHC) for SQSTM1, a marker of 
autophagy insufficiency, PAS staining, scanning electron microscopy (EM), 
immunofluorescence (IF) of podocin and IHC for WT1 in four groups of mice. Original 
magnification, ×400 for SQSTM1, PAS staining and WT-1, ×8,000 for scanning EM, 
×1,000 for IF of podocin. (B, C) Urinary albumin excretion levels in the indicated mouse 
groups at 4 weeks (B) and 8 weeks (C) after the tamoxifen injection. Urinary albumin 
excretion levels are expressed as log10 ratio urinary albumin/creatinine. (D) Quantitation 
of WT1-positive podocytes in glomeruli. All results are presented as mean ± SEM. *P < 
0.05, **P < 0.01. NS: not significant. 
 
Figure 3. Severe podocyte injury in iPodo-Atg5-/- mice with neuraminidase-induced 
structural endothelial dysfunction. (A) Scanning electron microscopy (EM) of 
glomeruli from HFD-fed Atg5f/f and HFD-fed iPodo-Atg5-/- mice. Original magnification: 
×8,000 and ×20,000 for details. (B) Time-dependent changes in urinary albumin excretion 
level in neuraminidase-injected Atg5f/f and iPodo-Atg5-/- mice. (C) Scanning electron 
microscopy (EM) of podocytes. Original magnification: ×8,000. All results are presented 
as mean ± SEM. *P < 0.05, **P < 0.01. NS: not significant. 
 
Figure 4. Enhanced endoplasmic reticulum (ER) stress iPodo-Atg5-/- mice with 
structural endothelial dysfunction. (A) Western blots of Atg7, cleaved caspase 3, and 
β-actin in cultured Atg7f/f and Atg7-/- podocytes stimulated with/without 5 g/dl bovine 
serum albumin. (B) Quantitative ratios of cleaved caspase 3 to β-actin (n=4). (C) 
Pathological event analysis of data from the proteomic analysis. The details of each 
calculated score, (p), (v), and (c), are explained in the Supplemental Method. (D) 
Immunohistochemical (IHC) for C/EBP homologous protein (CHOP). Original 
magnification: ×400. Semiquantitative measurement of CHOP-positive cells in glomeruli. 
(E) Urinary albumin excretion level in vehicle and TUDCA-treated groups. (D) Scanning 
electron microscopy (EM), immunofluorescent (IF) for podocin. Original magnification, 
×8,000 for scanning EM, and ×1,000 for IF of podocin and. All results are presented as 
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Albumin - +- +
Atg7+/+ Atg7-/-
C
rank Pathological event score score(p) score(v) score(c)
1 Apoptosis 169.294 1.09E-51 0.157 0.897
2 Endoplasmic Reticulum Stress 93.744 6.03E-29 0.133 0.314
3 Adipogenesis 42.153 2.05E-13 0.084 0.139
4 Necroptosis 38.921 1.92E-12 0.066 0.193
5 Excitotoxicity 29.905 9.95E-10 0.054 0.164
6 Epithelial-Mesenchymal 
Transition
28.548 2.55E-09 0.06 0.12
7 Cell Cycle 25.668 1.88E-08 0.036 0.286
8 Viral Infection 18.507 2.68E-06 0.042 0.099
9 Drug Transporter 18.235 3.24E-06 0.042 0.096
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Supplemental Materials
Supplemental Data. Whole data of the proteomic analysis.
Supplemental Figure 1. Study protocol for high-fat diet (HFD)-induced renal injury
in tamoxifen-inducible podocyte-specific Atg5-deficient mice (iPodo-Atg5-/- mice).
Supplemental Figure 2. Spatial interaction between endothelial dysfunction and
podocyte dysfunction in high-fat diet (HFD)-fed Atg5f/f and HFD-fed tamoxifen
(TM)-inducible podocyte-specific Atg5-deficient mice (iPodo-Atg5-/- mice).
Supplemental Figure 3. No interaction between nitric oxide synthase 3 (NOS3)
dysfunction and autophagy deficiency in albuminuria progression of diabetes.
Supplemental Figure 4. Severe podocyte injury in tamoxifen (TM)-inducible
podocyte-specific Atg5-deficient mice (iPodo-Atg5-/- mice) with neuraminidase-
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********
Supplemental Figure 1. Study protocol for high-fat diet
(HFD)-induced renal injury in tamoxifen-inducible podocyte-
specific Atg5-deficient mice (iPodo-Atg5-/- mice). (A) Study
protocol of diet intervention in iPodo-Atg5-/- mice. (B and C)
Comparisons of body weight (B) and fasting blood glucose levels
(C) in the indicated four groups of mice. All results are presented
as mean± SEM. *P < 0.05, **P < 0.01. NS: not significant.





















Supplemental Figure 2. Spatial interaction between endothelial dysfunction and podocyte dysfunction in high-fat diet
(HFD)-fed Atg5f/f and HFD-fed tamoxifen (TM)-inducible podocyte-specific Atg5-deficient mice (iPodo-Atg5-/- mice). Double
immunofluorescent (IF) of desmin and isolectin in glomeruli from the HFD-fed Atg5f/f and HFD-fed iPodo-Atg5-/-. Original
magnification ×1,000. The white boxes indicate the areas for the magnified pictures (A, B, C, D). The green and red color
























































































































































Supplemental Figure 3. No interaction between nitric oxide synthase 3 (NOS3) dysfunction and autophagy deficiency in
albuminuria progression of diabetes. We used NOS3-knockout mice as a model with functional endothelial damage. NOS3-
deficient mice were purchased from The Jackson Laboratory (Bar Harbor, ME). We crossbred TM-inducible podocyte-specific Atg5-
deficient mice with NOS3-knockout mice to produce Atg5 and NOS3-double knockout mice (iPodo-Atg5-/--NOS3-/-) (N=5). Age-
matched Atg5f/f- NOS3-knockout (Atg5f/f-NOS3-/-) mice were used as a simple NOS3-deficient control (N=5), and age-matched
Atg5f/f -NOS3+/+were used as a healthy control (N=5). We intraperitoneally injected TM (75 mg/kg/day for 5 consecutive days) into
these mice at 12 weeks of age. Urinary samples were collected at 4 and 8 weeks after the TM injection. Mice were sacrificed at 8
weeks after the TM injection.
(A) Protocol for generation of podocyte-specific autophagy-deficient mice with systemic NOS3 deficiency (NOS3-/--iPodo-Atg5-/-). (B
and C) Urinary albumin excretion levels in NOS3+/+-Atg5f/f, NOS3-/-- Atg5f/f, and NOS3-/--iPodo-Atg5-/- mice. Urinary albumin
excretion levels are expressed as log10 ratio urinary albumin/ creatinine. (D) Representative images of podocytes and glomerular
endothelial cells. Scanning electron microscopy (EM), and immunofluorescence (IF) of podocin, isolectin, and wheat germ
agglutinin (WGA). Original magnifications, ×8,000 for scanning EM of podocytes, ×20,000 for scanning EM of glomerular
endothelial cells, and ×1,000 for IF of podocin, isolectin, and WGA. The white boxes indicate the areas for the magnified pictures.




































Supplemental Figure 4. Severe podocyte injury in tamoxifen (TM)-inducible podocyte-specific Atg5-deficient mice (iPodo-
Atg5-/- mice) with neuraminidase-induced structural endothelial dysfunction. (A) Representative pictures of
immunofluorescent (IF) for nephrin and Wheat Germ Agglutinin (WGA). Original magnification: ×1,000. The green and red color
represents nephrin and WGA, respectively. (B) Study protocol of neuraminidase-induced structural endothelial dysfunction on
standard diet-fed Atg5f/f mice and iPodo-Atg5-/- mice. (C) Immunofluorescent (IF) for podocin. Original magnification: ×1,000 for IF
of podocin.
A Days after neuraminidase injection















HFD-induced diabetic rodent model
Eight-week-old male C57BL/6J mice were obtained from Clea Japan Inc. (Tokyo, Japan). The
mice were fed either a STD (10% of total calories from fat) or a HFD (60% of total calories from
fat). Mice in STD and HFD groups were sacrificed at 4, 8, 16, and 32 weeks, respectively, after
the initiation of dietary intervention.
HFD-induced diabetes in TM-inducible podocyte-specific autophagy-deficient mice
TM-inducible podocyte-specific Atg5-deficient mice (iPodo-Atg5-/-) were generated by
crossbreeding Atg5f/f mice with TM-inducible Nphs2-Cre transgenic mice (1). Atg5f/f mice were
used as a control group. Eight-week-old male Atg5f/f mice were fed the STD or HFD, and eight-
week-old male iPodo-Atg5-/- mice were fed the STD or HFD. Each group included 6–12 mice. To
induce deletion of the Atg5 gene, we intraperitoneally injected TM (Sigma-Aldrich, St. Louis,
MO) at a dose of 75 mg/kg/day for 5 consecutive days into the mice at 8 weeks after the dietary
intervention (2). Urinary samples were collected at 4 and 8 weeks after the TM injection. Mice
were sacrificed at 8 weeks after the TM injection.
Neuraminidase-induced endothelial damage model
We performed neuraminidase-induced removal of endothelial glycocalyx to establish the
structural endothelial damage model (3, 4). Eight-week-old male Atg5f/f mice and iPodo-Atg5-/-
mice were injected with neuraminidase via their tail vein at a dose of 0.001 U/gBW
(Neuraminidase from Vibrio cholerae Type III, Sigma-Aldrich). Urinary samples were collected
at the start and following four consecutive days after the neuraminidase injection. Mice were
sacrificed at the start of the study and at 1, 3, and 7 days after the neuraminidase injection. The
numbers of mice were 3–7 at each time point.
TUDCA treatment of neuraminidase-injected iPodo-Atg5-/- mice
iPodo-Atg5-/- mice were allocated into two groups: vehicle administered, as a control, (N=6) and
TUDCA (N=6) groups. TUDCA (500 mg/kg/day, Calbiochem-EMD Millipore, Billerica, MA) was
intraperitoneally administered for 3 consecutive days prior to the neuraminidase injection (5).
Urinary samples were collected at day 1 after the neuraminidase injection.
Bioinformatic analysis of protein expression data
Pathway analysis of the data list from the proteomic analysis was performed using KeyMolnet
(KM Data, Tokyo, Japan) (6). KeyMolnet is a bioinformatics integration platform that enables
analysis of specific pathways based on data collected from recent studies. By importing the list
of Entrez gene IDs, KeyMolnet automatically provides the corresponding molecules in the form
of nodes in a network. Among the various network-searching algorithms, the ‘interaction’ search
identifies molecular networks containing a group of molecules with differential regulation in the
present study. The significance was scored using the following formula in which O = the number
of overlapping molecular relationships between the extracted network and canonical pathway, V
= the number of molecules displayed in the search result, C = the number of molecules
belonging to specific pathways, T = the total number of molecules recorded in KeyMolnet, and X
= the sigma variable that defines incidental agreements.
Score(p) = = ∑#$%
&'((*, ) 𝑓 𝑋
𝑓 𝑋 =CCX • T-CCV-X/TCV,
with Score = −log2 [Score(p)]; Score(v) = O / V; Score(c) = O / C.
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